01/08/2021
02/08/2021
- Tuesday preview: RBA, StanChart in focus
- Europe close: Stocks advance, remain near record territory
- Smiths Group to sell medical unit to TA Associates for $2.3bn
- London close: Stocks finish firmer as deal fever continues
- Broker tips: Synthomer, Elementis
- Director dealings: Husband of Vodafone executive makes share purchase
- Camellia buys 80pc of fruit grower Bardsley
- Canaccord ups price target on Synthomer
- Berenberg raises target price on Elementis
- US open: Stocks start August in the green
- FTSE 250 movers: Meggitt rockets on takeover; Convatec hit by downgrade
- HSBC resumes dividends as first-half profits soar
- FTSE 100 movers: Melrose rallies on Meggitt read-across; AstraZeneca falls
- Beowulf Mining confident in Kosovo progress
- Duke Royalty enters financing agreement with Creo-Tech
- Foot Locker to buy two retailers for $1.1bn
- D4T4 Technologies acquires Bristol-based consultancy firm, appoints new CFO
- News Corp to buy oil data firm Opis in $1.15bn deal
- Square to buy Australia’s Afterpay for AUD39bn
- Directa Plus qualifies for Italian government loans
- more news from 02/08/2021...
03/08/2021
- Broker tips: Rightmove, HSBC
- Director dealings: Big Yellow CEO makes share sale
- Dalio says Beijing's crackdown on technology firms has been misinterpreted
- Immotion strikes deal for VR theatre at Sea Life Orlando
- Wolverine Worldwide acquires women's sportswear brand Sweaty Betty
- Seed Innovations puts another £0.22m into hemp firm Yooma
- FTSE 250 movers: Babcock bounces back; Rotork shares fall
- US open: Stocks mixed as Covid-19 concerns weigh on reopening plays
- FTSE 100 movers: BP gushes higher on results; Smiths Group tumbles
- Sanofi to buy Translate Bio to boost mRNA capabilities
- Allergy Therapeutics upbeat on ex-vivo study of peanut allergy vaccine
- DuPont beats Q2 expectations, raises FY guidance for a second time
- Credit Suisse stays at 'hold' on HSBC, now expects share buybacks
- Marvell Technology to buy chip start-up Innovium in $1.1bn deal
- Eli Lilly posts slightly weaker than expected Q2 profits
- PepsiCo to sell Tropicana, other juice brands to PE firm in $3.3bn deal
- US pre-open: Futures trade higher as economic growth worries subside
- Tuesday broker round-up
- Cambridge Cognition turns in 'strong financial performance' in H1
- London midday: FTSE maintains gains as BP, StanChart rally
- more news from 03/08/2021...
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.